Related Experiment Video
Updated: Sep 3, 2025

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
Gata6+ resident peritoneal macrophages promote the growth of liver metastasis
Mokarram Hossain1,2,3, Raymond Shim1,2, Woo-Yong Lee2
1Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.
Abstract:
Emerging evidence suggests that resident macrophages within tissues are enablers of tumor growth. However, a second population of resident macrophages surrounds all visceral organs within the cavities and nothing is known about these GATA6+ large peritoneal macrophages (GLPMs) despite their ability to invade injured visceral organs by sensing danger signals. Here, we show that GLPMs invade growing metastases that breach the visceral mesothelium of the liver via the "find me signal", ATP. Depleting GLPMs either by pharmacological or genetic tools, reduces metastases growth. Apoptotic bodies from tumor cells induces programmed cell death ligand 1 (PD-L1) upregulation on GLPMs which block CD8+ T cell function. Direct targeting of GLPMs by intraperitoneal but not intravenous administration of anti-PD-L1 reduces tumor growth. Thermal ablation of liver metastases recruits huge numbers of GLPMs and enables rapid regrowth of tumors. GLPMs contribute to metastatic growth and tumor recurrence.
Insights
Large peritoneal macrophages (GLPMs) promote liver metastasis growth by suppressing T cell function. Depleting GLPMs or blocking their PD-L1 pathway inhibits tumor progression and recurrence.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Resident macrophages are implicated in tumor progression.
- Large peritoneal macrophages (GLPMs) reside near visceral organs but their role in cancer is unknown.
- GLPMs can invade injured organs sensing danger signals.
Purpose of the Study:
- To investigate the role of GLPMs in liver metastasis.
- To understand the mechanisms by which GLPMs influence tumor growth and immune response.
Main Methods:
- Depletion of GLPMs using pharmacological and genetic tools.
- Analysis of GLPMs' interaction with tumor cells and immune cells.
- Administration of anti-PD-L1 therapy via intraperitoneal and intravenous routes.
- Assessment of tumor growth and recurrence after thermal ablation.
Main Results:
- GLPMs infiltrate liver metastases by sensing ATP.
- Depletion of GLPMs significantly reduces metastasis growth.
- Tumor cell apoptotic bodies upregulate PD-L1 on GLPMs, inhibiting CD8+ T cell function.
- Intraperitoneal anti-PD-L1 therapy reduces tumor growth, while intravenous administration is ineffective.
- Thermal ablation of metastases increases GLPM recruitment, leading to tumor regrowth.
Conclusions:
- GLPMs are critical drivers of liver metastatic growth and recurrence.
- Targeting GLPMs, particularly via PD-L1 blockade locally, offers a potential therapeutic strategy.
More Related Videos
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

